Skip to content

This clinical trial will be performed to understand the efficacy of Yashtimadhu Siddha Taila Nasya with Carboxy Methylcellulose Eye Drop in Dry Eye Syndrome which includes the symptoms such as Irritation or Foreign body sensation in eyes, Dryness, Itching, Blurry vision, Excessive blinking etc.

A Randomized Controlled Clinical Study to Evaluate the efficacy of Yashtimadhu Siddha Taila nasya and Carboxy Methylcellulose (CMC) Eye Drop in Dry Eye Syndrome. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103243
Enrollment
60
Registered
2026-02-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H049- Disorder of lacrimal system, unspecified

Interventions

None listed

Sponsors

PDEAs College of Ayurved and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients showing minimum 3 symptoms of dry eye syndrome Irritation, Itching or Foreign body sensation in eyes, Feeling of dryness, Blurring of vision, Ocular fatigue, Excessive blinking.

Exclusion criteria

Exclusion criteria: Known case of any acute infective condition or congenital anomalies of the eyes, Severe dry eye with corneal involvement, Tumours of the eye, Steven-Johnson syndrome, Post intraocular surgery operated within 1 month, No allergic rhinopathy.

Design outcomes

Primary

MeasureTime frame
To identify the difference in between the treatment for the management of dry eye syndrome. To compare the effectiveness of treatment over the period of time. To compare the efficacy of yashtimadhusiddha taila nasyakarma with CMC 0.5% eye drop.Timepoint: 15 days treatment with 2 follow ups on 7th and 15th day.

Secondary

MeasureTime frame
To assess the efficacy of Carboxymethylcellulose 0.5% eye drop with yashtimadhusiddha taila. To observe the adverse effect of drug, if any.Timepoint: 15 days treatment with 2 follow ups on 7th and 15th day.

Countries

India

Contacts

Public ContactDr Sandeep Darunde

PDEAs College of Ayurved and Research Centre

swd420@gmail.com8983088238

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026